ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.